Thrombosis & Haemostasis, TH,TH Open/X
Dec 3, 2025, 02:33
Cancer Patients․ Bleeding Risk Rises with Anticoagulants + Antiangiogenics ?
Thrombosis and Haemostasis Journal has shared on X:
” Does Anticoagulants with Angiogenesis Inhibitors Increase Bleeding in Cancer ?
In this network meta-analysis, Chen et al. found that adding anticoagulation to high-dose bevacizumab or antiangiogenic TKIs might increase bleeding risk.”
Read more here.
Stay updated with Hemostasis Today.
-
Jan 25, 2026, 15:57Céline Chapelle Shares Clinical Predictors From the API-CAT Trial
-
Jan 25, 2026, 15:42Francesco Lo Monaco on Heart Disease Starting Quiet While Your Labs Speak First
-
Jan 25, 2026, 15:25Muhammad Ibrahim on Efficacy and Safety of Extended DOACs Use in VTE
-
Jan 25, 2026, 15:08Tushar Pandey on Managing Thrombotic Thrombocytopenic Purpura
-
Jan 25, 2026, 14:55Carolina Contreras Cuevas Shares a Nationwide Study on VTE in PAD
-
Jan 25, 2026, 14:40Jeannie Devereaux Links PRP and Physical Therapy
-
Jan 25, 2026, 14:25Heghine Khachatryan on Anticoagulation After AFib Ablation: New Evidence from NEJM
-
Jan 25, 2026, 12:42Lale Tokgözoğlu on Cardiovascular Risk Factors in Women
-
Jan 25, 2026, 12:32Dino Mehic on Bleeding Assessment Tools and QoL in BDUC